JP TSE 4931 Chemicals

Shinnihonseiyaku Co., Ltd.

新日本製薬株式会社

Revenue

¥41.1B

≈ $260.7M

Net income

¥2.6B

≈ $16.2M

Total assets

¥28.3B

≈ $179.0M

Equity ratio

80.7%

Share price at fiscal year-end: ¥2,289 · market capitalization ¥50.0B · P/E 19.0 · P/B 2.19

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Total assets	Net assets	Equity ratio	Source
Sep 2025	¥41.1B	¥2.6B	¥28.3B	¥22.8B	80.7%	EDINET (consol.)
Sep 2024	¥40.0B	¥2.8B	¥27.2B	¥21.8B	80.1%	EDINET (consol.)
Sep 2023	¥37.7B	¥2.4B	¥25.5B	¥19.7B	77.1%	EDINET (consol.)
Sep 2022	¥36.1B	¥2.4B	¥23.9B	¥17.9B	75.1%	EDINET (consol.)
Sep 2021	¥33.9B	¥2.3B	¥23.2B	¥16.2B	69.6%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.